Benzinga | May 11, 2021 04:37PM EDT

Asensus Surgical Q1 Adj. EPS $(0.06) Beats $(0.07) Estimate, Sales $2.10M Beat $1.40M Estimate

Asensus Surgical (AMEX:ASXC) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 85.37 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $2.10 million which beat the analyst consensus estimate of $1.40 million by 50.00 percent. This is a 250.00 percent increase over sales of $600.00 thousand the same period last year.